What is true about Glutamine in total parenteral nutrition (TPN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glutamine: Properties and Role in Total Parenteral Nutrition

Glutamine is a substrate for gluconeogenesis and is not an essential amino acid under normal conditions, but it is now recommended to be supplemented in total parenteral nutrition for critically ill patients. 1

Key Properties of Glutamine

  • Non-essential amino acid: Under normal conditions, glutamine is not an essential amino acid as it has an endogenous production rate of 50-80g/24h in adults, primarily in skeletal muscle 1

  • Substrate for gluconeogenesis: Glutamine participates in glucose metabolism and serves as a carrier for nitrogen and carbon between organs 1

  • Intestinal function: Glutamine increases intestinal cellularity and helps maintain intestinal structure and function 2

  • Supplementation in TPN: Glutamine is now supplied in total parenteral nutrition, particularly for critically ill patients 1

Role in Critical Illness

Glutamine becomes conditionally essential during critical illness for several reasons:

  • During critical illness, increased demand for glutamine utilization (for immune activity and repair) is not adequately met by endogenous production 1

  • Plasma glutamine levels fall during critical illness, and low levels are associated with worse outcomes 1

  • Glutamine depletion occurs in muscle tissue during catabolic stress, which cannot be reversed by conventional nutritional means 3

Glutamine Supplementation in TPN

The ESPEN guidelines recommend:

  • When parenteral nutrition is indicated in ICU patients, the amino acid solution should contain 0.2-0.4 g/kg/day of L-glutamine 1

  • Glutamine-containing dipeptides (alanyl-glutamine or glycyl-glutamine) are used because crystalline L-glutamine is poorly soluble and degrades during heat sterilization 1

  • Clinical outcome studies have shown reduced mortality risk with PN containing glutamine in critically ill patients (RR 0.67, CI 0.48-0.92) 1

Clinical Benefits of Glutamine Supplementation

  • Helps maintain intestinal structure and function 2
  • May reduce infections and hospital length of stay 4
  • Supports immune function 1
  • Acts as a precursor for nucleotides and cellular protection through glutathione 1

Important Considerations and Caveats

  • More recent guidelines have become more cautious about glutamine supplementation, downgrading recommendations from Grade B to Grade 0 (may be considered) 1

  • A large multicenter RCT in well-nourished patients undergoing major gastrointestinal surgery found no significant benefit for postoperative complication rates 1

  • High-dose glutamine administration in critically ill patients with organ dysfunction has been associated with increased mortality 1

  • The route of administration matters: parenteral glutamine produces higher plasma concentrations compared to enteral administration 1

In summary, glutamine is a non-essential amino acid under normal conditions that becomes conditionally essential during critical illness. It is a substrate for gluconeogenesis, increases intestinal cellularity, and is now recommended as a supplement in total parenteral nutrition for critically ill patients who cannot be adequately fed enterally.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.